John Harrahy, PhD

Placeholder Person Graphic
Sanofi
Senior Director, BioAnalytics Genomic Medicine Unit
John Harrahy is a Senior Director of the BioAnalytics department in the Genomic Medicine Unit at Sanofi. His team supports process development from FIH through licensure, helping to characterize, define, and measure the critical quality attributes of viral and nonviral gene therapy therapeutics, including AAV's and LNP's. Prior to joining Sanofi, John worked at Amgen in Process Development in the Pivotal Attribute Sciences Department, leading a team that performed characterization and analytical development studies to support licensure, and he led Amgen's Analytical Target Profile workstream. He earned his PhD at Oregon State University.

Related Articles

Industry Perspectives on Practical Application of Platform Analytical Procedures
Features
Industry Perspectives on Practical Application of Platform Analytical Procedures

Pharmaceutical and biotechnology companies employ platform analytical procedures in the development stages of their synthetic and biological drug products and are beginning to leverage them for commercial products. This shift is supported by the acceptance of platform procedures in the recently adopted ICH Q2(R2) and ICH Q14. Six case studies are shared in this article to highlight how...

Industry Perspectives on Practical Application of Platform Analytical Procedures
Features
Industry Perspectives on Practical Application of Platform Analytical Procedures

Pharmaceutical and biotechnology companies employ platform analytical procedures in the development stages of their synthetic and biological drug products and are beginning to leverage them for commercial products. This shift is supported by the acceptance of platform procedures in the recently adopted ICH Q2(R2) and ICH Q14. Six case studies are shared in this article to highlight how...